Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionEarly HAART Initiation May Not Reduce Actual Reproduction Number and Prevalence of MSM Infection: Perspectives from Coupled within- and between-Host Modelling Studies of Chinese MSM PopulationsConditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR.Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmiThe clinical utility of viral load monitoring in HIV infection: strengths and limitationsAntenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressorsFetal allostimulation of maternal cells: a potential mechanism for perinatal HIV transmission following obstetrical hemorrhage.Expanded Highly Active Antiretroviral Therapy Coverage - A Powerful Strategy to Curb Progression to AIDS, Death and New InfectionsAntiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?HIV-1: maternal prognosis.Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy.The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus.Detection of human immunodeficiency virus type 1 (HIV-1) DNA and RNA sequences in HIV-1 antibody-positive blood donors in Uganda by the Roche AMPLICOR assay.Materno-fetal transmission of human immune deficiency virusThe effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana.Different outcomes of vertical transmission of hepatitis C virus in a twin pregnancy.Significance of placental damage in vertical transmission of human immunodeficiency virus.Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood.Influence of maternal CD4 levels on the predictive value of virus load over mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1). Study Group for Vertical Transmission.
P2860
Q24550678-6B50B473-F23D-48B3-B81E-53ED0F35804AQ28550445-630217FF-7CD0-44DA-8CAA-CF14A104341FQ30424775-2733525B-2F7C-41A3-8AA8-DBF84E997D89Q33647187-40CDD1DB-64DA-4AE7-8F50-50BF5241C1D7Q33661973-8B6ADB9C-9A7B-4FD4-AC78-005CDC3B1A66Q33668265-602CDFCB-2B2C-497E-BAAB-D5558480E515Q33700962-20409F35-A58D-4794-B9F1-77DF28301FBDQ33781934-62A831C9-D1F6-4867-A988-23D76953D020Q33936351-52D57D9E-A07A-41B1-8A2D-E1DED25C26C1Q34057338-3775D7C9-E523-426B-B971-FDFF5A1CD404Q34079006-7BB8C7AF-438F-4B83-8EB2-D3CFE285C9BEQ34085345-0CD4EF7D-490F-4750-80D0-433C0205C050Q34485535-28A06A3E-EB86-4EF3-BF4A-27980959306FQ35557314-309DE25E-4D6B-4320-9B67-1EF6A6263A4FQ35695524-A4F18B0E-9D5F-4EF5-ABDB-AD91C8CDA356Q36011358-53D45BDE-28FC-4AAA-9EEF-CAD4222DAF7CQ36033283-896B631A-5082-4901-ABDD-87F9433F47A9Q36543907-EBAE36B6-2EFB-4C5F-8F94-AF744ACD01DBQ36625385-9900C644-86A6-4F8B-86E6-876A5237E909Q36736405-9614DEA3-7AE6-487F-B5FB-F1D3C757F5B7Q36748059-E2C13856-4590-4EDD-B9EE-D44E37E402F7Q37503621-5C1E5F62-4C1C-4926-A936-137768C7F406Q40799780-2BDDA431-522F-4085-96A1-22FABA60F54CQ44041366-44F3426F-FA9C-4897-9C03-37D4230638D8Q44775305-F79AE6F5-13D8-416D-8459-8FDACA0D7ECDQ45399239-24D5AE12-E3BC-4431-87A1-B1A9F795CD25Q45749160-3678C791-1216-40B5-9D47-50ECC9BC75EEQ45749775-22B875DD-FA3C-4D7B-8101-FE58ACD8B9A1
P2860
Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Maternal plasma human immunode ...... r mother-to-child transmission
@ast
Maternal plasma human immunode ...... r mother-to-child transmission
@en
type
label
Maternal plasma human immunode ...... r mother-to-child transmission
@ast
Maternal plasma human immunode ...... r mother-to-child transmission
@en
prefLabel
Maternal plasma human immunode ...... r mother-to-child transmission
@ast
Maternal plasma human immunode ...... r mother-to-child transmission
@en
P2093
P2860
P356
P1476
Maternal plasma human immunode ...... r mother-to-child transmission
@en
P2093
N Hutcheon
P2860
P304
12100-12104
P356
10.1073/PNAS.92.26.12100
P407
P577
1995-12-01T00:00:00Z